PHGE

BiomX Inc.

Biological Products, (No Diagnostic Substances)NYSENon-accelerated filer<br>Smaller reporting company

Total Trades

7

Buys

3

Sells

4

Largest Trade

$100K–$500K

Insiders

3

Institutional Funds

9

Inst. Value

$100K–$500K

Activist Filings

40

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Oron AssafChief Business Off…SELL$1K–$15K11K$0.37Dec 1, 2023
Oron AssafChief Business Off…BUY<$1K3K$0.27May 24, 2023
Oron AssafChief Business Off…BUY$1K–$15K8K$0.28May 22, 2023
OrbiMed Israel BioFund GP Limited Partnership10% OwnerBUY$50K–$100K348K$0.24Mar 17, 2023
Ugwumba ChidozieInsiderSELL$15K–$50K75K$0.35Nov 14, 2022
Ugwumba ChidozieInsiderSELL$100K–$500K277K$0.39Nov 14, 2022
Ugwumba ChidozieInsiderSELL$100K–$500K289K$0.64Nov 14, 2022
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 9 funds holding

FundShares
Nantahala Capital Management, LLC115K
Ikarian Capital, LLC19K
JPMORGAN CHASE & CO14K
BARCLAYS PLC1K
Clear Street Group Inc.120
UBS Group AG98
SBI Securities Co., Ltd.20
DANSKE BANK A/S1
CWM, LLC1

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

Alyeska Investment Group, L.P.

SC 13G/A · Feb 17, 2026

2.5%

38K shares

Nantahala Capital Management, LLC

SC 13G/A · Feb 13, 2026

10.0%

157K shares

10.0%

494K shares

Orin Hirschman

SC 13G/A · Jan 30, 2026

0.1%

38K shares

Pyu Pyu Capital, LLC

SC 13D · Jan 26, 2026

20.0%

381K shares

Morgan Stanley

SC 13G/A · Aug 7, 2025

0.0%

0 shares

Morgan Stanley

SC 13G · Aug 5, 2025

7.1%

1.9M shares

ORBIMED ISRAEL GP LTD.

SC 13D/A · Jun 23, 2025

1.0%

276K shares

Nantahala Capital Management, LLC

SC 13G/A · May 15, 2025

10.0%

2.5M shares

Alyeska Investment Group, L.P.

SC 13G · May 15, 2025

9.3%

2.3M shares

Rodney Hodges

SC 13G · May 15, 2025

7.6%

2.0M shares

Orin Hirschman

SC 13G · May 8, 2025

6.3%

1.6M shares

Cystic Fibrosis Foundation

SC 13G/A · Mar 4, 2025

10.0%

2.5M shares

10.0%

7.8M shares

Cystic Fibrosis Foundation

SC 13G/A · Feb 14, 2025

20.0%

4.1M shares

Nantahala Capital Management, LLC

SC 13G · Nov 13, 2024

10.0%

1.8M shares

AMR Action Fund, L.P.

SC 13G/A · Nov 13, 2024

4.9%

877K shares

John H. Burbank III

SC 13G/A · Nov 4, 2024

2.9%

510K shares

OrbiMed Israel GP Ltd.

SC 13D/A · Jul 18, 2024

10.0%

17.9M shares

10.0%

77.8M shares

4.4%

3.1M shares

Cystic Fibrosis Foundation 2.

SC 13G/A · Mar 26, 2024

15.6%

9.3M shares

AMR Action Fund, L.P.

SC 13G · Mar 25, 2024

5.5%

3.1M shares

5.5%

3.1M shares

OrbiMed Israel GP Ltd.

SC 13D/A · Mar 20, 2024

19.9%

12.6M shares

OrbiMed Israel GP Ltd.

SC 13D/A · Mar 8, 2024

9.9%

4.6M shares

MMCAP International Inc. SPC

SC 13G/A · Feb 13, 2024

3.2%

1.5M shares

Johnson & Johnson

SC 13G/A · Feb 2, 2024

4.6%

2.1M shares

Cystic Fibrosis Foundation

SC 13G/A · Jan 30, 2024

9.9%

4.6M shares

Rodney Hodges

SC 13G · Sep 29, 2023

6.2%

2.8M shares

John H. Burbank III

SC 13G · Jun 23, 2023

10.0%

4.6M shares

OrbiMed Israel GP Ltd.

SC 13D/A · May 8, 2023

9.9%

4.6M shares

OrbiMed Israel GP Ltd.

SC 13D/A · Mar 17, 2023

10.5%

3.5M shares

Cystic Fibrosis Foundation

SC 13G · Mar 8, 2023

8.1%

2.8M shares

MMCAP International Inc. SPC

SC 13G/A · Feb 14, 2023

7.1%

2.2M shares

Chidozie Ugwumba

SC 13G/A · Feb 13, 2023

3.1%

923K shares

Chidozie Ugwumba

SC 13G/A · Nov 14, 2022

10.0%

3.0M shares

5.0%

1.5M shares

Thomas Layton Walton

SC 13G · Feb 14, 2022

0.0%

0 shares

Chidozie Ugwumba

SC 13G · Feb 14, 2022

19.3%

5.5M shares

View on Google Finance →